Strabismus clinical trials
6 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
- Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
- The Alaska Oculocardiac Reflex Study
- Intraoperative OCT Guidance of Intraocular Surgery II
- Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
- Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Strabismus” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.